Lower Cerebrospinal Fluid Amyloid-β(42) Predicts Sooner Time to Antipsychotic Use in Alzheimer’s Disease

BACKGROUND: Cerebrospinal fluid (CSF) biomarkers of amyloid-β(42) (Aβ(42)) and phosphorylated-tau help clinicians accurately diagnose Alzheimer’s disease (AD). Whether biomarkers help prognosticate behavioral and psychological symptoms of dementia (BPSD) is unclear. OBJECTIVE: Determine whether CSF...

Descripción completa

Detalles Bibliográficos
Autores principales: Cahan, Joshua G., Vassar, Robert, Bonakdarpour, Borna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357113/
https://www.ncbi.nlm.nih.gov/pubmed/37483323
http://dx.doi.org/10.3233/ADR-220064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357113/
https://www.ncbi.nlm.nih.gov/pubmed/37483323
http://dx.doi.org/10.3233/ADR-220064

Ejemplares similares